Business · 08/09/2014
FDA Corrects Postmarketing Safety Reports Document
The Food and Drug Administration (FDA) is correcting a document related to postmarketing safety reports for human drugs and biological products, which was published without the required RIN number and in the Notice category in the Federal Register on August 14, 2014.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →